litlas
Log inCreate account

Ralph R. Weichselbaum

Active 1977–2025

Also published as
Ralph R Weichselbaum
278
Papers
56,685
Citations
126
h-index
267
i10-index

Citations

Citations per year for Ralph R. Weichselbaum1978: 5 citations1979: 7 citations1980: 7 citations1981: 5 citations1982: 14 citations1983: 9 citations1984: 7 citations1985: 24 citations1986: 15 citations1987: 11 citations1988: 17 citations1989: 19 citations1990: 34 citations1991: 39 citations1992: 49 citations1993: 78 citations1994: 100 citations1995: 133 citations1996: 193 citations1997: 279 citations1998: 275 citations1999: 362 citations2000: 403 citations2001: 389 citations2002: 397 citations2003: 394 citations2004: 358 citations2005: 267 citations2006: 230 citations2007: 216 citations2008: 186 citations2009: 200 citations2010: 218 citations2011: 263 citations2012: 313 citations2013: 267 citations2014: 364 citations2015: 448 citations2016: 380 citations2017: 438 citations2018: 630 citations2019: 1,861 citations2020: 2,252 citations2021: 2,282 citations2022: 1,810 citations2023: 1,550 citations2024: 2,120 citations2025: 1,212 citations2026: 44 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,748 citing papers, 30.9% of this breakdownChina: 4,407 citing papers, 20.2% of this breakdownUnited Kingdom: 1,010 citing papers, 4.6% of this breakdownGermany: 976 citing papers, 4.5% of this breakdownFrance: 794 citing papers, 3.6% of this breakdownItaly: 694 citing papers, 3.2% of this breakdownCanada: 667 citing papers, 3% of this breakdownJapan: 650 citing papers, 3% of this breakdownNetherlands: 507 citing papers, 2.3% of this breakdownAustralia: 420 citing papers, 1.9% of this breakdownSpain: 375 citing papers, 1.7% of this breakdownSwitzerland: 368 citing papers, 1.7% of this breakdown
0%30.9%Other 19.4%

Institutions

Fields

  • Medicine43.6%
  • Biochemistry, Genetics and Molecular Biology30.6%
  • Immunology and Microbiology12.4%
  • Engineering7%
  • Computer Science1.5%
  • Materials Science1.2%
  • Other3.7%

Topics

  • Cancer Immunotherapy and Biomarkers5.8%
  • Immunotherapy and Immune Responses3.6%
  • Nanoplatforms for cancer theranostics3.5%
  • interferon and immune responses2.3%
  • Immune cells in cancer2.2%
  • Head and Neck Cancer Studies1.8%
  • Other80.8%

Coauthors

All papers

Open in search
  1. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

    Authors: Liufu Deng, Hua Liang, Meng Xu, Xuanming Yang, Byron Burnette, Ainhoa Arina, Xiao-Dong Li, Helena J. Mauceri, Michael A. Beckett, Thomas E. Darga, Xiaona Huang, Thomas F. Gajewski, Zhijian J. Chen, Yang‐Xin Fu, Ralph R. Weichselbaum - Immunity 2014 cited by 2,079

  2. Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice

    Authors: Liufu Deng, Hua Liang, Byron Burnette, Michael A. Beckett, Thomas E. Darga, Ralph R. Weichselbaum, Yang‐Xin Fu - Journal of Clinical Investigation 2014 cited by 2,090

  3. Oligometastases.

    Authors: Samuel Hellmän, Ralph R. Weichselbaum - Journal of Clinical Oncology 1995 cited by 2,452

  4. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells

    Authors: Dali Han, Jun Liu, Chuanyuan Chen, Lihui Dong, Yi Liu, Renbao Chang, Xiaona Huang, Yuanyuan Liu, Jian‐Ying Wang, Urszula Dougherty, Marc B. Bissonnette, Bin Shen, Ralph R. Weichselbaum, Meng Xu, Chuan He - Nature 2019 cited by 1,002

  5. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling

    Authors: Yaoyao Shi, Wenxin Zheng, Kaiting Yang, Katharine G. Harris, Kaiyuan Ni, Lai Xue, Wenbin Lin, Eugene B. Chang, Ralph R. Weichselbaum, Yang‐Xin Fu - The Journal of Experimental Medicine 2020 cited by 385

  6. Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade

    Authors: Si Wei, Hua Liang, Jason Bugno, Qi Xu, Xingchen Ding, Kaiting Yang, Yanbin Fu, Ralph R. Weichselbaum, Xin Zhao, Liangliang Wang - Gut 2021 cited by 298

  7. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy

    Authors: Liangliang Wang, Xiaoyang Dou, Shijie Chen, Xianbin Yu, Xiaona Huang, Linda Zhang, Yantao Chen, Jiaai Wang, Kaiting Yang, Jason Bugno, Sean P. Pitroda, Xingchen Ding, András Piffkó, Wei Si, Chao Chen, Hualiang Jiang, Bing Zhou, Steven J. Chmura, Cheng Luo, Hua Liang, Chuan He, Ralph R. Weichselbaum - Cancer Cell 2023 cited by 236

  8. Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration

    Authors: Kaiting Yang, Wenbo Han, Xiaomin Jiang, András Piffkó, Jason Bugno, Chuanhui Han, Sirui Li, Hua Liang, Ziwan Xu, Wenxin Zheng, Liangliang Wang, Jiaai Wang, Xiaona Huang, Jenny P.‐Y. Ting, Yang‐Xin Fu, Wenbin Lin, Ralph R. Weichselbaum - Nature Nanotechnology 2022 cited by 206

  9. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance

    Authors: Hua Liang, Liufu Deng, Yuzhu Hou, Xiangjiao Meng, Xiaona Huang, Enyu Rao, Wenxin Zheng, Helena J. Mauceri, Matthias Mack, Meng Xu, Yang-Xin Fu, Ralph R. Weichselbaum - Nature Communications 2017 cited by 478

  10. Radiotherapy and immunotherapy: a beneficial liaison?

    Authors: Ralph R. Weichselbaum, Hua Liang, Liufu Deng, Yang‐Xin Fu - Nature Reviews Clinical Oncology 2017 cited by 1,061

  11. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia

    Authors: Xingchen Ding, Liangliang Wang, Xuedong Zhang, Junlong Xu, Peifeng Li, Hua Liang, Xianbin Zhang, Li Xie, Zihan Zhou, Jia Yang, Ralph R. Weichselbaum, Jinming Yu, Man Hu - Journal of Hematology & Oncology 2021 cited by 242

  12. The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity

    Authors: Byron Burnette, Hua Liang, Youjin Lee, Lukasz K. Chlewicki, Nikolai N. Khodarev, Ralph R. Weichselbaum, Yang‐Xin Fu, Sogyong Auh - Cancer Research 2011 cited by 856

  13. Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy

    Authors: Kuangda Lu, Chunbai He, Nining Guo, Christina Chan, Kaiyuan Ni, Guangxu Lan, Haidong Tang, Charles A. Pelizzari, Yang-Xin Fu, Michael T. Spiotto, Ralph R. Weichselbaum, Wenbin Lin - Nature Biomedical Engineering 2018 cited by 594

  14. Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy

    Authors: Yuzhu Hou, Hua Liang, Enyu Rao, Wenxin Zheng, Xiaona Huang, Liufu Deng, Yuan Zhang, Xinshuang Yu, Meng Xu, Helena J. Mauceri, Ainhoa Arina, Ralph R. Weichselbaum, Yang‐Xin Fu - Immunity 2018 cited by 264

  15. Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling

    Authors: Meng Xu, Pu Yang, Dali Han, Yaoyao Shi, Xuezhi Cao, Hua Liang, Xiang Chen, Xiao-Dong Li, Liufu Deng, Zhijian J. Chen, Ralph R. Weichselbaum, Yang-Xin Fu - Immunity 2017 cited by 305

  16. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

    Authors: Ralph R. Weichselbaum, Hemant Ishwaran, Taewon Yoon, Dimitry S.A. Nuyten, Samuel W. Baker, Nikolai N. Khodarev, Andy Su, Arif Y. Shaikh, Paul D. Roach, Bas Kreike, Bernard Roizman, Jonas Bergh, Yudi Pawitan, Marc J. van de Vijver, Andy J. Minn - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 622

  17. Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy

    Authors: Wenyao Zhen, Ralph R. Weichselbaum, Wenbin Lin - Advanced Materials 2022 cited by 160

  18. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

    Authors: Youjin Lee, Sogyong Auh, Yugang Wang, Byron Burnette, Yang Wang, Yuru Meng, Michael A. Beckett, Rohit Sharma, Robert Chin, Tony Tu, Ralph R. Weichselbaum, Yang‐Xin Fu - Blood 2009 cited by 1,316

  19. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy

    Authors: Chunbai He, Xiaopin Duan, Nining Guo, Christina Chan, Christopher Poon, Ralph R. Weichselbaum, Wenbin Lin - Nature Communications 2016 cited by 755

  20. Radiotherapy and immunotherapy: open questions and future strategies

    Authors: Kelli B. Pointer, Sean P. Pitroda, Ralph R. Weichselbaum - Trends in cancer 2021 cited by 154

  21. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy

    Authors: Youyou Li, Jing Liu, Yimei Chen, Ralph R. Weichselbaum, Wenbin Lin - Advanced Science 2024 cited by 120

  22. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

    Authors: Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison, Sean P. Pitroda, J.M. Melotek, Yuanyuan Zha, Hania Al‐Hallaq, Ainhoa Arina, Nikolai N. Khodarev, Linda Janisch, Paul J. Chang, Jyoti D. Patel, Gini F. Fleming, John W. Moroney, Manish Sharma, Julia White, Mark J. Ratain, Thomas F. Gajewski, Ralph R. Weichselbaum, Steven J. Chmura - Journal of Clinical Oncology 2018 cited by 587

  23. Improved survival time trends for glioblastoma using the SEER 17 population-based registries

    Authors: Matthew Koshy, John L. Villano, Therese A. Dolecek, Andrew Howard, Usama Mahmood, Steven J. Chmura, Ralph R. Weichselbaum, Bridget J. McCarthy - Journal of Neuro-Oncology 2011 cited by 478

  24. Tumor-associated fibroblasts predominantly come from local and not circulating precursors

    Authors: Ainhoa Arina, Christian Idel, Elizabeth Hyjek, Maria‐Luisa Alegre, Ying Wang, Vytautas P. Bindokas, Ralph R. Weichselbaum, Hans Schreiber - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 223